Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone-Sensitive Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00412022
What this trial is testing

HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

Who this might be right for
Breast Cancer
National Cancer Institute, Naples 1,294
Large-scale testing (Phase 3)Study completedNCT00066703
What this trial is testing

Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 2,672
Testing effectiveness (Phase 2)WithdrawnNCT01005641
What this trial is testing

ELBA: Exemestane and Lapatinib in Advanced Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute, Naples
Not applicableStudy completedNCT01720602
What this trial is testing

Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
University of Washington 15
Not applicableStudy completedNCT03594578
What this trial is testing

Prospective Thinking in Hormone-Responsive Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Virginia Polytechnic Institute and State University 89
Early research (Phase 1)Study completedNCT00933309
What this trial is testing

The Impact of Obesity and Obesity Treatments on Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT01205685
What this trial is testing

Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer

Who this might be right for
Hormone-sensitive Metastatic Breast Cancer
Vanderbilt-Ingram Cancer Center 11
Early research (Phase 1)Study completedNCT04712396
What this trial is testing

Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Who this might be right for
Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
AstraZeneca 11
Testing effectiveness (Phase 2)Study completedNCT03747042
What this trial is testing

Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer

Who this might be right for
Breast Cancer Female
University of Texas Southwestern Medical Center 61
Large-scale testing (Phase 3)Study completedNCT03969121
What this trial is testing

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Who this might be right for
Breast Cancer FemaleHormone Receptor Positive Malignant Neoplasm of Breast
Kyoto Breast Cancer Research Network 141
Not applicableStudy completedNCT00884143
What this trial is testing

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

Who this might be right for
Post MenopausalBreast Cancer
AstraZeneca 515
Not applicableLooking for participantsNCT06855784
What this trial is testing

Time-Restricted Eating in Menopause and HOrmone-sensitive Breast Cancers (TREMHO)

Who this might be right for
MenopauseObesity and Overweight
University Hospital, Geneva 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT06590857
What this trial is testing

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Who this might be right for
Metastatic Breast CancerHER2-negative Breast CancerER+ Breast Cancer+7 more
RayzeBio, Inc. 16
Testing effectiveness (Phase 2)WithdrawnNCT01013506
What this trial is testing

Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03844685
What this trial is testing

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88
Testing effectiveness (Phase 2)UnknownNCT00927511
What this trial is testing

A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)

Who this might be right for
Breast Cancer
Regina Elena Cancer Institute 104
Not applicableNot Yet RecruitingNCT07735897
What this trial is testing

Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women

Who this might be right for
Breast Cancer
MedicalExcellence 1,483
Testing effectiveness (Phase 2)Study completedNCT00871858
What this trial is testing

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

Who this might be right for
Breast Cancer
Institut Bergonié 120
Testing effectiveness (Phase 2)UnknownNCT00931450
What this trial is testing

Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Institut Català d'Oncologia 70
Large-scale testing (Phase 3)UnknownNCT00912548
What this trial is testing

Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women

Who this might be right for
Breast Cancer
Korean Breast Cancer Study Group 1,234
Next Page